Accéder au contenu
Merck

Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results.

Infection (1990-01-01)
H Thoumsin, M Aghayan, R Lambotte
RÉSUMÉ

Pregnancy induces anatomical and physiological changes in the urinary tract. In this condition a bacteriuria, even asymptomatic, may lead more frequently to pyelonephritis. Asymptomatic bacteriuria in pregnant women has therefore got to be treated. According to recent studies, long course antibiotherapy did not prove to be more effective than a single-dose one in the case of non-complicated bacteriuria. Moreover, the maternal and foetal toxicity should be reduced in the latter regimen. In this paper we present the preliminary results of our study comparing a single-dose treatment by fosfomycin trometamol (3 g) and nitrofurantoin (200 mg per day during a week).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Nitrofurantoïne, 98.0-102.0% (EP, UV)
USP
Nitrofurantoïne, United States Pharmacopeia (USP) Reference Standard
Supelco
Nitrofurantoïne, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Nitrofurantoïne, VETRANAL®, analytical standard